Algorae Pharmaceuticals Ltd
F:LHI0
Algorae Pharmaceuticals Ltd
F:LHI0
Price:
0.0035
EUR
Market Closed
Market Cap:
€5.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Algorae Pharmaceuticals Ltd
F:LHI0
|
AU |
|
R
|
Rio Grande Resources Ltd
F:488
|
CA |
|
Pond Technologies Holdings Inc
F:4O0
|
CA |
|
T
|
Technogym SpA
SWB:TN2
|
IT |
|
Volta Metals Ltd
F:D0W
|
CA |
|
Marinomed Biotech AG
F:93Z
|
AT |
|
S
|
Sonaecom SGPS SA
ELI:SNC
|
PT |
|
Leocor Gold Inc
OTC:LECRF
|
CA |
|
Liberty Global PLC
NASDAQ:LBTYA
|
UK |
|
Parex Resources Inc
TSX:PXT
|
CA |
|
Marco Polo Marine Ltd
SGX:5LY
|
SG |
|
N
|
Neotech Metals Corp
OTC:NTMFF
|
CA |
|
S
|
Seafco PCL
SET:SEAFCO
|
TH |
|
Western Uranium & Vanadium Corp
OTC:WSTRF
|
CA |
|
C
|
Caterpillar Inc
BMV:CAT
|
US |
Intrinsic Value
Not Available for LHI0
There is not enough data to reliably calculate the intrinsic value for Algorae Pharmaceuticals Ltd.
Do our valuations actually work? See backtest results .
Alternatives to LHI0
Fundamental Analysis
What Algorae Pharmaceuticals Does
Algorae Pharmaceuticals Ltd is a small Australian drug-development company that uses artificial intelligence to help find and design new medicines. It does not sell finished drugs today; instead, it works on early-stage pharmaceutical research and builds a pipeline of candidate treatments that may later be licensed or developed further with partners.
- Headquarters
- Australia AU
- IPO date
- Sep 1, 2004
Financials
Efficiency
Earnings Waterfall
Algorae Pharmaceuticals Ltd
Algorae Pharmaceuticals Ltd
